# Xiaoyu Jia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaoyu-jia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,351 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 32 |
| i10-index | 42 |
| Last Known Institution | Johnson & Johnson (United States) |
| OpenAlex ID | https://openalex.org/A5014205869 |
| ORCID iD | 0009-0000-0590-5624 |
| Works | 80 |

## Researcher papers

- [Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes](https://scholariq.org/papers/adverse-symptom-event-reporting-by-patients-vs-clinicians-relationships-with/)
- [Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data](https://scholariq.org/papers/circulating-tumour-cells-as-prognostic-markers-in-progressive-castration/)
- [Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/circulating-tumor-cell-biomarker-panel-as-an-individual-level-surrogate-for/)
- [Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer](https://scholariq.org/papers/randomized-open-label-phase-iii-trial-of-docetaxel-plus-high-dose-calcitriol/)
- [Survival on Dialysis Post–Kidney Transplant Failure: Results From the Scientific Registry of Transplant Recipients](https://scholariq.org/papers/survival-on-dialysis-post-kidney-transplant-failure-results-from-the-scientific/)
- [Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer](https://scholariq.org/papers/bone-scan-index-a-quantitative-treatment-response-biomarker-for-castration/)
- [A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas After Limb-Sparing Surgery Without Adjuvant Radiation](https://scholariq.org/papers/a-postoperative-nomogram-for-local-recurrence-risk-in-extremity-soft-tissue/)
- [A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers](https://scholariq.org/papers/a-novel-survival-based-tissue-microarray-of-pancreatic-cancer-validates-muc1-and/)
- [Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin](https://scholariq.org/papers/serious-infection-risk-and-immune-recovery-after-double-unit-cord-blood/)
- [Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy](https://scholariq.org/papers/dermatofibrosarcoma-protuberans-dfsp-predictors-of-recurrence-and-the-use-of/)
- [490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial](https://scholariq.org/papers/490mo-niraparib-nira-and-abiraterone-acetate-plus-prednisone-aap-in-chinese/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)

## Researcher university

- [Johnson & Johnson (United States)](https://scholariq.org/institutions/johnson-and-johnson-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.